Xeljanz Side Effects
Generic name: tofacitinib
Note: This document contains side effect information about tofacitinib. Some of the dosage forms listed on this page may not apply to the brand name Xeljanz.
Some side effects of Xeljanz may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to tofacitinib: oral tablet
Get emergency medical help if you have any of these signs of an allergic reaction while taking tofacitinib (the active ingredient contained in Xeljanz) hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Serious and sometimes fatal infections may occur during treatment with tofacitinib. Stop using this medicine and call your doctor right away if you have signs of infection such as:
-
fever, chills, tired feeling, night sweats;
-
stomach pain, loss of appetite, diarrhea, weight loss, or a change in your bowel habits;
-
pain or burning when you urinate;
-
body aches, sore throat, flu symptoms, sores in your mouth and throat;
-
stabbing chest pain, wheezing, feeling short of breath, cough with mucus or blood; or
-
skin redness and swelling.
Tofacitinib may also cause severe liver symptoms. Call your doctor at once if you have any of these liver symptoms:
-
low fever, itching;
-
upper stomach pain, loss of appetite;
-
dark urine, clay-colored stools; or
-
jaundice (yellowing of the skin or eyes).
Common side effects may include:
-
headache; or
-
mild cold symptoms such as runny or stuffy nose.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to tofacitinib: oral tablet
General
The most common serious adverse reactions were serious infections.
Cardiovascular
Common (1% to 10%): Hypertension
Dermatologic
Frequency not reported: Rash, erythema, pruritus
Gastrointestinal
Common (1% to 10%): Diarrhea
Frequency not reported: Abdominal pain, dyspepsia, vomiting, gastritis, nausea
Hematologic
Frequency not reported: Anemia, neutropenia, lymphopenia
Hepatic
Common (1% to 10%): AST elevation, ALT elevation
Frequency not reported: Hepatic steatosis, elevated bilirubin
Immunologic
Very common (10% or more): Overall infections (up to 22%)
Frequency not reported: Serious infection (most commonly pneumonia, cellulitis, herpes zoster and urinary tract infection), other non-TB opportunistic infection
Metabolic
Frequency not reported: Dehydration, increased total cholesterol, increased LDL cholesterol, increased HDL cholesterol, increased triglycerides
Musculoskeletal
Frequency not reported: Musculoskeletal pain, arthralgia, tendonitis, joint swelling
Nervous system
Common (1% to 10%): Headache
Frequency not reported: Paresthesia
Oncologic
Frequency not reported: Lung cancer, breast cancer, gastric cancer, colorectal cancer, renal cell cancer, prostate cancer, lymphoma, malignant melanoma, non-melanoma skin cancer
Other
Frequency not reported: Pyrexia, fatigue, peripheral edema
Psychiatric
Frequency not reported: Insomnia
Renal
Common (1% to 10%): Increased serum creatinine
Respiratory
Common (1% to 10%): Nasopharyngitis, upper respiratory tract infection
Frequency not reported: Dyspnea, cough, sinus congestion, tuberculosis (TB)
More Xeljanz resources
- Xeljanz Prescribing Information (FDA)
- Xeljanz MedFacts Consumer Leaflet (Wolters Kluwer)
- Xeljanz Consumer Overview
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


